Adjuvant treatment for triple-negative breast cancer: a retrospective study of immunotherapy with autologous cytokine-induced killer cells in 294 patients

• Published in: Cancer biology & medicine Vol. 16; no. 2; pp. 350 - 360
• Main Authors: Yuhan, Zhang, Shuaibing, Wang, Beibei, Yang, Su, Lu, Yiyi, Du, Hong, Liu
• Format: Journal Article
• Language: English
• Published: China The Second Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin 300060, China%Oncology Department, China National Petroleum Corporation Central Hospital, Langfang 065000, China 01.05.2019; Chinese Anti-Cancer Association; China Anti-Cancer Association
• Subjects: cytokine-induced killer cell; disease-free survival; Immunotherapy; Original; overall survival; prognosis; triple-negative breast cancer; overall survival; triple-negative breast cancer; disease-free survival; cytokine-induced killer cell; prognosis; Immunotherapy

To examine the efficacy and safety of a sequential combination of chemotherapy and autologous cytokine-induced killer (CIK) cell treatment in triple-negative breast cancer (TNBC) patients. A total of 294 post-surgery TNBC patients participated in the research from January 1, 2009 to January 1, 2015....